Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
Crossref DOI link: https://doi.org/10.1007/s13300-020-00842-w
Published Online: 2020-10-04
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guja, Cristian
Frías, Juan P.
Suchower, Lisa
Hardy, Elise
Marr, Galina
Sjöström, C. David
Jabbour, Serge A.
Text and Data Mining valid from 2020-10-04
Version of Record valid from 2020-10-04
Article History
First Online: 4 October 2020